An Experimental Ebola Vaccine Just Took A Giant Leap Forward
The National Institutes of Health's initial trial found the experimental vaccine for the Ebola virus so far is safe for humans and produced an immune response. Researches found anti-Ebola antibodies in the blood of all 20 healthy adult volunteers. The findings mean the potential vaccine can move to the next phase of testing, which could involve thousands of participants and could start early next year.
The trial vaccine includes genetic material from two Ebola strains, including the one fueling the deadly outbreak in West Africa, which has now infected nearly 16-thousand people.
Produced by Devan Joseph. Video courtesy of Associated Press.
Follow BI Video: On Facebook
- Luxury “floating” beach unveiled in France, termed an “ecological aberration”
- Scientists think they’ve spotted 60 potential alien power plants in the Milky Way!
- Bread, butter, milk-based health drinks, cooking oils classified as ultra-processed food, ICMR advises restriction
- Debt, equity holders approve merger of IDFC with IDFC First Bank
- Sunrisers Hyderabad to take on Punjab Kings as they look to grab the second spot in IPL points table
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market